In our previous studies, AveI was identified as a negative regulator for avermectin biosynthesis in Streptomyces avermitilis NRRL8165, and the aveI-null mutant of NRRL8165 could produce at least 10-fold more avermectin B1a than its wild-type strain. In order to explore the regulatory mechanism by which aveI affects avermectin biosynthesis, in this study, we performed a global comparative gene expression analysis between aveI deletion mutant 8165DI and its wild-type strain using NimbleGen microarrays in combination with real-time reverse transcriptase-PCR. The results showed the aveI deletion has caused global changes beyond the avermectin biosynthetic gene cluster. The aveI gene not only negatively affected expression of the avermectin biosynthetic gene cluster but also affected expression of oligomycin and filipin biosynthetic clusters. In addition, the genes involved in precursor biosyntheses for avermectin or other antibiotics, such as crotonyl-CoA reductase and methylmalonyl-CoA decarboxylase, were also upregulated in aveI mutant. Furthermore, genes in several key primary metabolic pathways, such as protein synthesis and fatty acid metabolism, were found downregulated in the mutant. These results suggested that the aveI gene may be functioning as a global regulator involved in directing carbon flux from primary to secondary metabolism.
Introduction
Streptomyces species are among the most numerous and ubiquitous soil-dwelling bacteria (Hodgson, 2000) that have a complex morphological differentiation and are the major natural producers of many bioactive secondary metabolites, including a variety of antibiotics with important uses in human and veterinary medicine and agriculture, as well as of antiparasitic agents, herbicides, and many enzymes important in industries (Demain, 1999; Khosla et al., 1999) . Among various secondary metabolites, avermectin and its analogues produced by Streptomyces avermitilis are important commercial antiparasitic agents widely applied in the fields of veterinary and human medicine (Burg et al., 1979; Egerton et al., 1979; Yoon et al., 2004) . Avermectins are a series of eight major 16-membered pentacyclic lactone compounds (macrocyclic polyketides), among which the B1 fraction, especially B1a, has the most effective antiparasitic activity (Burg et al., 1979; . Recently, several avermectin derivatives, such as ivermectin and doramectin, have also come into commercial use, which were shown to have a more advantageous antiparasitic efficacy than avermectin (Chabala et al., 1980; Aziz et al., 1982; Toutain et al., 1997) .
The gene cluster for avermectin biosynthesis has been well characterized a decade ago (Ikeda et al., 1999) , and recently, the genome sequencing of S. avermitilis was also completed (Omura et al., 2001; Yoon et al., 2004) . While genome sequence analyses reveal a significant number of signal transduction genes to be present in S. avermitilis (Shi & Zhang, 2004; Zhang & Shi, 2005; Wei et al., 2007) , current knowledge regarding the regulatory mechanism of avermectin biosynthesis is still very limited. In an early study, introduction of multiple copies of afsR2, a global regulatory gene from Streptomyces lividans, which was previously reported to highly stimulate two structurally unrelated antibiotics, actinorhodin and undecylprodigiosin, in both S. lividans and its close relative Streptomyces coelicolor increased the total avermectin production by 1.5-2.3-fold (Lee et al., 2000) . In a recent study, a eukaryotic-type serine/ threonine protein kinase AfsKav was found to be involved in the regulation of the gene expression of S-adenosylmethione synthetase, which is important for avermectin production in S. avermitilis (Rajkarnikar et al., 2006 (Rajkarnikar et al., , 2007 . In another recent study, a putative pathway-specific regulatory gene of avermectin biosynthesis, aveR, which belongs to the LAL family of regulatory genes (Ikeda et al., 1999) , was inactivated by gene replacement in the chromosome of S. avermitilis, resulting in the complete loss of avermectin production (Kitani et al., 2009) . The aveR mutant was unable to convert an avermectin intermediate to any avermectin derivatives, and complementation by intact aveR and its proper upstream region restored avermectin production in the mutant, suggesting that AveR is a positive regulator controlling the expression of both polyketide biosynthetic genes and postpolyketide modification genes in avermectin biosynthesis (Kitani et al., 2009) . These studies strongly suggested that avermectin biosynthesis is a process under tight control of multilevel signal transduction mechanisms, and a better understanding and manipulation of these mechanisms could represent an important strategy for further improving the production of various industrial compounds (Alper et al., 2006; Nevoigt et al., 2007; Stephanopoulos, 2007) .
The DNA microarray technology has been used to explore transcriptional profiles of various growth conditions and genome differences for several Streptomyces strains (Gadgil et al., 2005; Mehra et al., 2006; Kang et al., 2007; Hsiao & Kirby, 2008) , considerably facilitating our understanding of Streptomyces metabolism. In a recent study, DNA microarray was used to determine the differential gene expression between the low producer S. avermitilis ATCC31267 and the high producer S. avermitilis ATCC31780 (Im et al., 2007) . The analysis revealed 50 S. avermitilis genes that were expressed at least twofold higher in ATCC31780, including polyketide synthase (PKS) genes and several regulatory genes (i.e. SAV213, SAV3818, and SAV4023). The results demonstrated that the application of microarray technology allows better interpretation of the genetic mechanism underlying avermectin overproduction, and the information obtained will be useful for the construction of engineered strains with better production.
A transcriptional activator of actinorhodin biosynthesis, AtrA, was previously characterized in S. coelicolor A3(2), and an orthologue of atrA, named aveI, is present in the S. avermitilis NRRL8165 genome (Uguru et al., 2005) . In our previous study (Chen et al., 2008) , we found that deletion of aveI gene led to an increased biosynthesis of avermectin B1a by 4 10-fold; however, electrophoretic mobility shift assays revealed that AveI does not bind specifically to the promoter region of aveR in vitro, suggesting that its effects on avermectin biosynthesis were not through a direct control of the biosynthetic cluster. To seek more clues regarding the possible regulatory mechanism of aveI, in the present study, we used whole-genome DNA microarray, in combination with real-time reverse transcriptase (RT)-PCR, to determine the differential gene expression between the aveI deletion strain 8165DI and its wild-type strain NRRL8165. The results suggested that AveI may function as a global regulator and part of its role may be involved in directing carbon flux from primary to secondary metabolism in S. avermitilis.
Materials and methods

Bacterial strains and fermentation conditions
The bacterial strains used in this study were S. avermitilis NRRL8165 and the aveI deletion mutant 8165DI (Chen et al., 2008) . Avermectin B1a fermentation was performed as described previously (Chen et al., 2008 Ltd, China) were used. Streptomyces avermitilis wild-type and mutant strains were grown at 30 1C on mannitolsoybean (MS) agar (Thompson & Hopwood, 1980; Kieser et al., 2000) for 4 days at 30 1C before they were inoculated into 30 mL BioK fermentation seed medium in 250-mL flasks. After incubation for 40 h at 30 1C on a rotary shaker (200 r.p.m.) , cultures were transinoculated into three parallel 250-mL flasks with 30-mL BioK fermentation medium by 5% inoculation and grown for 10 days at 30 1C on a rotary shaker (200 r.p.m.).
Determination of avermectin B1a
For avermectin extraction, 7 mL methanol was added to 3 mL fermentation broth in a 20-mL tube and treated in an ultrasonic cleaner for 20 min. After centrifugation, the supernatants were analyzed using an Agilent Eclipse XDB-C8 column (4.6 Â 150 mm) maintained at 30 1C, with a solvent system of methanol-water (85 : 15, v/v) and a flow rate of 0.9 mL min À1 . The column effluent was monitored at 245 nm and the elution time for component B1a was 5.701 min. Commercial avermectin B1a (95.9%, w/w) (Hisun, Zhejiang, China) was used to construct the standard curve for quantitative determination.
RNA preparation and microarray assays
RNA used for microarray assays were prepared as described previously (Chen et al., 2008) . Mycelia of S. avermitilis wildtype or mutant strains from the BioK fermentation broth were collected at days 5, 7, and 10, and then frozen immediately in liquid nitrogen and ground into a powder. RNA isolation was carried out with Trizol TM (Invitrogen) following the procedures recommended by the manufacturer. NimbleChip Expression Oligonucleotide Customer Microarrays (Roche NimbleGen) designed for S. avermitilis were used. For each gene, 10 different oligonucleotides were designed and every oligonucleotide was repeated five times on each slide. Each slide contained 385 000 60mer oligonucleotides. The array, containing a total of 7645 ORFs of S. avermitilis, was manufactured as described before (Nuwaysir et al., 2002) . NIMBLESCAN software was used for data analyses. Microarray assays, including labeling, hybridization, and washing, and microarray data normalization were performed by Shanghai Biochip Co. Ltd (China), according to standard protocols suggested by the NimbleChip TM Expression Array User's guide (version 1.0, NimbleGen Systems Inc.).
Real-time RT-PCR analyses
The real-time RT-PCR was performed according to the methods described previously (Lu et al., 2007) . The RT-PCR reactions used SYBR Premix ExTaq TM (Toyota, Japan). The primers used for RT-PCR are listed in Table 1 . The PCR conditions were 95 1C for 60 s, followed by 40 cycles of 95 1C for 15 s and 65 1C for 60 s. The amounts of transcript in different samples were determined from the number of cycles (C) needed for the reactions to reach a common threshold (t), and a standard curve was constructed between the C t values and DNA with serial dilutions. Three parallel RT-PCR reactions were used for each transcript in any given sample. The 16s rRNA gene was used as an internal control.
Microarray dataset accession number
The raw microarray dataset analyzed in this paper has been submitted at NCBI Gene Expression Omnibus under the accession number GSE16892.
Results and discussion
Growth time course and avermectin B1a production Growth and avermectin production were comparatively studied to determine the optimal time points for gene expression analysis (Fig. 1) . Avermectin measurements were performed at three time points (days 5, 7, and 10), which roughly corresponded to the middle exponential, late exponential and stationary phases of cell growth. The results showed that although both the mutant and the wild-type strain had a similar growth rate, the deletion mutant Length of PCR products (bp) Fig. 1 . Growth (dry weight) and avermectin B1a production in the strains Streptomyces avermitilis NRRL8165 and 8165DI (the aveI mutant strain) at days 5, 7, and 10.
produced from 2-to 10-fold more avermectin B1a than the parental strain at different time points. Cells collected from these three time points in both cultures were used for RNA isolation.
An overview of the transcriptomic analysis RNA was isolated from both the fermentation broth of S. avermitilis NRRL8165 and the aveI mutant at three time points, days 5, 7 and 10, and then used for microarray analysis. Pair-wise comparison of gene expression indicated that 337 genes (19 genes upregulated and 318 genes downregulated), 126 genes (43 genes upregulated and 83 genes downregulated), and 313 genes (182 genes upregulated and 131 genes downregulated) showed greater than twofold changes (mutant/wild type 4 2.0 or o 0.5) at days 5, 7 and 10, respectively. Across three time points of measurements, a total of 607 genes were responsive when the aveI mutant was compared with its wild-type strain. The functional classification of the responsive genes is listed in Table  2 . Responsive genes were found in almost every aspect of S. avermitilis metabolism, suggesting that the effects exerted by the aveI gene may be at a global level. Based on the number of responsive genes (twofold cutoff), the most broadly affected category was 'energy metabolism,' followed by 'transport and binding proteins' and 'protein synthesis' categories (Table 2) .
Microarray data quality
To assess the reliability of microarray data independently, real-time RT-PCR was used to measure the expression level of 12 selected genes. Real-time RT-PCR was performed for RNA samples of the 8165DI mutant and the wild-type strain from all three time points (days 5, 7, and 10). The ratios between the 8165DI mutant and the wild-type strain were calculated and plotted (Fig. 2) . Overall, the results showed a significant correlation between microarray data and realtime RT-PCR data (Pearson's correlation coefficient r 2 = 0.55, 0.92 and 0.93 for genes from days 5, 7, and 10, respectively, and r 2 = 0.78 for all genes from all three time points). The relatively low correlation at day 5 may be due to the fact that the ratio changes for the selected 12 genes were less significant at day 5 (mostly o 2-fold). In addition, we had confirmed the increased expression of the PKS genes for avermectin and aveR in the aveI mutant as compared with the wild-type strain at day 10 using semi-quantitative RT-PCR analysis in our previous study (Chen et al., 2008) , which was also consistent with the data obtained from this microarray study. These results suggested that microarray data were consistent with real-time RT-PCR data, and hence, the microarray results appeared to be reliable.
Effects of aveI deletion on transcription of the avermectin gene cluster and other polyketide genes
Consistent with the overproduction of avermectin B1a in the aveI mutant (Fig. 1) , transcriptional level of all genes in the avermectin biosynthetic gene cluster (SAV_936-SAV_953) is significantly upregulated in the aveI mutant at all three time points tested (Fig. 3a) . In general, the expression level of the avermectin biosynthetic gene cluster appeared to be increasing when cell cultures grew from the middle exponential to the stationary phases, reaching their highest expression levels at day 10 (Fig. 3a) . The increased expression of aveR (encoding the pathwayspecific regulator for avermectin biosynthesis) in the microarray data was also confirmed by real-time RT-PCR (Fig. 2) . Oligomycin and its analogues are another group of antibiotics produced by S. avermitilis. Oligomycin and its structurally related analogues are a series of 26-membered macrocyclic lactones that display a variety of significant biological activities, especially strong antifungal effects (Masamune et al., 1958) , specific inhibition of mitochondrial ATPase (Tzagoloff & Meagher, 1972) . The gene cluster for oligomycin biosynthesis has been cloned and characterized (Omura et al., 2001; Ikeda et al., 2003) ; however, there is so far no knowledge regarding the regulation of oligomycin biosynthesis. Comparative microarray analysis showed that several genes in the oligomycin gene cluster, including SAV_2895 and SAV_2896 encoding modular PKS, SAV_2901 and SAV_2902 encoding LuxR-family transcriptional regulator were upregulated in the aveI mutant at day 10 (Fig. 3b) .
Streptomyces avermitilis also produces filipin, a 28-membered macrolide antifungal polyene (Ikeda et al., 2003) . Filipin is also widely used as a probe for cholesterol in biological membranes and as a prominent diagnostic tool for type C Niemann-Pick disease (Bergy & Eble, 1968) . Comparative microarray analysis showed that 11 out of 12 genes in the filipin gene cluster were upregulated, including two position-specific P450 hydroxylases, C26-specific CYP105P1 and C1 0 -specific CYP105D6, filipin modular PKSs (pteA1-pteA5), ferredoxin (fdxI, pteE), and putative zinc-binding dehydrogenase (pteB) gene were upregulated in the aveI mutant (Fig. 3c) . It is worth noting that the expression levels of both oligomycin and filipin biosynthetic clusters were low in the middle and late exponential phases, and the expression level was elevated only in the stationary phase (day 10).
Effects of aveI deletion on the transcription of precursor biosyntheses for antibiotics
In Streptomyces, methylmalonyl-CoA and ethylmalonylCoA are two of the most common chain extender units for the biosynthesis of many polyketide antibiotics, and several pathways for their generation have been proposed (Hopwood & Sherman, 1990; Wu et al., 2005) . Our microarray analysis showed that crotonyl-CoA reductase was upregulated by 4.6-fold and methylmalonyl-CoA decarboxylase was upregulated by 2.4-fold in aveI mutant at day 10, which could potentially lead to increased supply of precursors into the antibiotics.
Effects of aveI deletion on primary metabolism
Although compared with the wild-type strain NRRL8165, no change of morphological phenotypes was observed in the 8165DI strain when it was grown on a solid MS plate, and no change of growth rate was observed when grown in either YEME medium or fermentation medium (Chen et al., 2008) , a number of genes involved in key primary metabolism pathways were downregulated in the mutant strain (Fig. 3d-g ). The energy metabolic pathway was affected significantly, particularly the downregulated oxidative phosphorylation, which is required for the ATP synthesis (Fig.  3d) . Of the protein biosynthesis, many ribosome and elongation factor genes were downregulated, especially at days 5 and 7 (Fig. 3e) . Gene cluster SAV2880-SAV2886, implicated in oxidative phosphorylation, was repressed significantly in the mutant. In addition, several genes in the tricarboxylic acid cycle (Fig. 3f ) and fatty acid metabolism (Fig. 3g) were also downregulated in the aveI mutant.
Effects of aveI deletion on regulatory genes
The microarray results showed that a total of 37 genes involved in regulatory functions, such as transcriptional regulator or two-component signal genes, were differentially expressed in the mutant (Table 3) . One of the interesting cases was of SAV_775, which encodes a putative TetR-family transcriptional regulator and was significantly upregulated 3.5-6.7-fold in the mutant as compared with the wild-type strain at all three time points of sampling (Table 3) . Bioinformatic analysis suggested that SAV_775 had high homology with actII-1, a probable transcriptional regulator located in the biosynthetic gene cluster of blue-colored actinorhodin in S. coelicolor (Bentley et al., 2002) . In addition, three genes adjacent to SAV_775 (SAV_776, SAV_777 and SAV_778) were also significantly upregulated in the mutant at all three time points of sampling (Table 3) . More interestingly, genomic analysis showed that SAV_775, SAV_776, SAV_777, and SAV_778 are not organized in the same operon, and currently no function annotation is available for SAV_776, SAV_777, and SAV_778, although they are conserved in several other Streptomyces genomes. Further study is needed to explore the exact function of this regulatory gene and its relationships with aveI.
Conclusion
In this study, we reported the comparative transcriptomic analyses between the aveI deletion strain S. avermitilis 8165DI and the wild-type strain NRRL8165 using NimbleGen oligonucleotide microarrays coupled with real-time RT-PCR. The results showed that aveI deletion has caused global changes beyond just the avermectin biosynthetic gene cluster. The aveI gene not only negatively affected expression of the avermectin biosynthetic gene cluster but also affected expression of oligomycin and filipin biosynthetic clusters. In addition, the results showed that genes involved in precursor biosyntheses for avermectin or other antibiotics, such as crotonyl-CoA reductase and methylmalonyl-CoA decarboxylase, were also upregulated in aveI mutant. On the other hand, genes in several key primary metabolic pathways, such as protein synthesis and fatty acid metabolism, were found to be downregulated in the mutant. Furthermore, the aveI deletion also caused increased expression of several other regulatory genes. These results suggested that aveI gene may be functioning as a global negative regulator involved in directing carbon flux from primary to secondary metabolism. In this study, to verify the data quality, we have compared more accurate real-time RT-PCR data with the microarray data. The results showed very good correlation for most genes (R 2 = 0.78), suggesting very good quality of the microarray data. However, due to the not-well-developed overexpression system in S. avermitilis, biological significance of the AveI-deletion-responsive genes identified by this microarray-based study has not yet been verified. In the future, application of technologies, such as chromatin immunoprecipitation (ChIP) with microarray technology (chip) (ChIP on chip) (Ren et al., 2000) will help address this issue by determining the direct gene targets affected by AveI regulator. In addition, we also performed a comparison between this microarray analysis with an earlier one by Im et al. (2007) , who identified 50 differentially expressed genes between the low producer S. avermitilis ATCC31267 and the high producer S. avermitilis ATCC31780. The results showed that, besides the avermectin biosynthetic genes, three genes upregulated in the aveI mutant (i.e. SAV_594 encoding a gas vesicle synthesis protein, SAV_2895 encoding a modular PKS gene, and SAV_5346 encoding a hypothetical protein) were also found upregulated in high producer S. avermitilis ATCC31780 (Im et al., 2007) . While the roles of these three genes in avermectin production may be interesting and worth further investigation, the relatively low similarity of gene expression patterns between two studies suggested that different mechanisms may be responsible for the enhanced production of avermectin in the aveI mutant and ATCC31780 strain (Im et al., 2007; Chen et al., 2008) . This study provides valuable information for better understanding of the complicated mechanism governing avermectin overproduction and the other cellular metabolism in S. avermitilis.
